SCHEMBL18164752

SCHEMBL18164752

CC1(C)OB(c2cccc(-c3ccc4oc5c6ccccc6ccc5c4c3)c2)OC1(C)C

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LIPG Q9Y5X9 5/20 0.48
LPL P06858 4/20 0.48
CYP1A1 P04798 12/20 0.36
CYP1B1 Q16678 12/20 0.36
CYP1A2 P05177 11/20 0.36
PRKDC P78527 2/20 0.36
KDM4E B2RXH2 1/20 0.36
PDE5A O76074 1/20 0.36
ALDH1A1 P00352 1/20 0.36
TP53 P04637 1/20 0.36
ABCB1 P08183 1/20 0.36
CYP3A4 P08684 1/20 0.36
CYP2D6 P10635 1/20 0.36
MAPT P10636 1/20 0.36
CYP19A1 P11511 1/20 0.36
CYP2C9 P11712 1/20 0.36
HPGD P15428 1/20 0.36
TSHR P16473 1/20 0.36
CYP2B6 P20813 1/20 0.36
TACR2 P21452 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22087260 0.92 LIPG (0.49) LIPGLPLCYP1A1CYP1B1CYP1A2
SCHEMBL17807008 0.92 LPL (0.49) LIPGLPLCYP1A1CYP1B1CYP1A2
SCHEMBL20109574 0.91 LIPG (0.60) LIPGLPLCYP1A1CYP1B1CYP1A2
SCHEMBL24239245 0.90 LPL (0.50) LIPGLPLCYP1A1CYP1B1CYP1A2
SCHEMBL24239147 0.90 LIPG (0.49) LIPGLPLCYP1A1CYP1B1CYP1A2
SCHEMBL19832039 0.88 LPL (0.48) LIPGLPLCYP1A1CYP1B1CYP1A2
SCHEMBL22087511 0.87 LPL (0.43) LIPGLPLCYP1A1CYP1B1CYP1A2
SCHEMBL22087264 0.85 LIPG (0.50) LIPGLPLCYP1A1CYP1B1KDM4E
SCHEMBL17929516 0.84 LIPG (0.49) LIPGLPLCYP1A2KDM4EALDH1A1
SCHEMBL22161508 0.83 LIPG (0.52) LIPGLPLCSF1R

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20180123048-A1 COMPOUND FOR ORGANIC ELECTRIC ELEMENT, ORGANIC ELECTRIC ELEMENT COMPRISING THE SAME AND ELECTRONIC DEVICE THEREOF DUK SAN NEOLUX CO., LTD. (KR) 2018-05-03 US disclosed
US-20180123048-A1 COMPOUND FOR ORGANIC ELECTRIC ELEMENT, ORGANIC ELECTRIC ELEMENT COMPRISING THE SAME AND ELECTRONIC DEVICE THEREOF DUK SAN NEOLUX CO., LTD. (KR) 2018-05-03 US disclosed
WO-2016167491-A1 COMPOUND FOR ORGANIC ELECTRONIC ELEMENT, ORGANIC ELECTRONIC ELEMENT USING SAME, AND ELECTRONIC APPARATUS 덕산네오룩스 주식회사 2016-10-20 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20180123048-A1 COMPOUND FOR ORGANIC ELECTRIC ELEMENT, ORGANIC ELECTRIC ELEMENT COMPRISING THE SAME AND ELECTRONIC DEVICE THEREOF PIEZO1, OCIAD1, LEF1 LIPG 1295/4885LPL 2598/4885CYP1A1 316/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.